Table 1 Baseline demographic data in total and related to HCV status
All n (%) | HCV positive n (%) | HCV negative n (%) | p value | |
|---|---|---|---|---|
Total | 450 (100)a | 215 (100) | 235 (100) | |
Gender | 0.750 | |||
Male | 336 (74.7) | 162 (75.3) | 174 (74) | |
Female | 114 (25.3) | 53 (24.7) | 61 (26) | |
Age at registration | N/Ab | |||
Mean age (years) | 34.60 | 35.30 | 33.95 | |
Median age (years) | 31 | 32 | 31 | |
Total number of NSP visits | < 0.001 | |||
1 | 41 (9.1) | 17 (7.9) | 24 (10.2) | |
2–10 | 161 (35.8) | 63 (29.3) | 98 (41.7) | |
11–100 | 207 (46) | 105 (48.8) | 102 (43.4) | |
> 100 | 41 (9.1) | 30 (14) | 11 (4.7) | |
Country of birth | 0.486 | |||
Sweden | 310 (88.1) | 152 (86.9) | 158 (89.3) | |
Other | 42 (11.9) | 23 (13.1) | 19 (10.7) | |
Home region | 0.01 | |||
Uppsala | 283 (65.8) | 121 (59.6) | 162 (71.4) | |
Other | 147 (34.2) | 82 (40.4) | 65 (28.6) | |
Age of debut of drug use | N/A | |||
Mean age (years) | 14.81 | 14.20 | 15.37 | |
Median age (years) | 14 | 14 | 15 | |
Age of debut of injection drug use | N/A | |||
Mean age (years) | 22.45 | 21.10 | 23.70 | |
Median age (years) | 20 | 19 | 21 | |
Level of education | < 0.001 | |||
Partial elementary | 49 (11.2) | 28 (13.5) | 21 (9.1) | |
Elementary | 174 (39.8) | 99 (47.8) | 75 (32.6) | |
Upper secondary | 153 (35) | 59 (28.5) | 94 (40.9) | |
Vocational | 33 (7.6) | 15 (7.2) | 18 (7.8) | |
University | 28 (6.4) | 6 (2.9) | 22 (9.6) | |
Living situation the past 3 months | 0.009 | |||
Own housing | 172 (38.5) | 65 (30.5) | 107 (45.7) | |
Shared housing | 116 (26) | 59 (27.7) | 57 (24.4) | |
Homeless/Shelter | 98 (21.9) | 51 (23.9) | 47 (20.1) | |
Assisted living | 20 (4.5) | 11 (5.2) | 9 (3.8) | |
Treatment home | 13 (2.9) | 9 (4.2) | 4 (1.7) | |
Prison and probation service | 12 (2.7) | 10 (4.7) | 2 (0.9) | |
Other | 16 (3.6) | 8 (3.8) | 8 (3.4) | |
Employment the past 3 months | < 0.001 | |||
Full-time or part-time employment | 70 (15.8) | 26 (12.4) | 44 (19) | |
Unemployed | 180 (40.7) | 97 (46.2) | 83 (35.8) | |
Sick/Activity compensation | 133 (30.1) | 58 (27.6) | 75 (32.3) | |
Student | 16 (3.6) | 2 (1) | 14 (6) | |
Other | 43 (9.7) | 27 (12.9) | 16 (6.9) | |
Primary drug used the past 12 months | 1.000 | |||
Amphetamine | 264 (59.1) | 127 (59.1) | 137 (59.1) | |
Heroin | 102 (22.8) | 49 (22.8) | 53 (22.8) | |
Other | 81 (18.1) | 39 (18.1) | 42 (18.1) | |
Shared needle, syringe or paraphernalia past month | 0.065 | |||
Yes | 198 (44.9) | 103 (49.5) | 95 (40.8) | |
No | 243 (55.1) | 105 (50.5) | 138 (59.2) | |
HBV status at registration (anti-Hbc)c | 0.375 | |||
Positive | 5 (1.2) | 1 (0.5) | 4 (1.8) | |
Negative | 427 (98.8) | 205 (99.5) | 222 (98.2) |